Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer

This publication has 12 references indexed in Scilit:

• Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer
  Journal of Clinical Oncology, 1999
• GIVIO-SITAC 01
  Cancer, 1998
• Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.
  Journal of Clinical Oncology, 1997
• Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report
  Annals of Internal Medicine, 1995
• Timing the collaborative analysis of three trials comparing 5‐FU plus folinic acid (FUFA) to surgery alone in the management of resected colorectal cancer: A national cancer institute of canada clinical trials group (NCIC‐CTG) perspective
  Statistics in Medicine, 1994
• Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
  Gastroenterology, 1994
• The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.
  Journal of Clinical Oncology, 1993
• P31 Salvaging clinical trials forced to terminate early by results of external information
  Controlled Clinical Trials, 1993
• Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
  New England Journal of Medicine, 1990
• Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators
  Published by Elsevier